Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $556K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Agilent A:US USD 3M 0
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Catalent CTLT:US USD 2M 0
Charles River Laboratories CRL:US USD 512K 3K
Danaher DHR:US USD 9M 0
Dentsply International XRAY:US USD 3M 0
Exact Sciences EXAS:US USD 1.8M 19K
General Electric GE:US USD 15M 0
Henry Schein HSIC:US USD 1000K 0
IQVIA Holdings Inc IQV:US USD 2.57M 431K
Myriad Genetics MYGN:US USD 800K 0
NanoString Technologies NSTG:US USD 5K 0
OraSure Technologies OSUR:US USD 0 0
Patterson Companies PDCO:US USD 977K 7K
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Repligen RGEN:US USD 556K 0
Waters WAT:US USD 1.63M 2K
West Pharmaceutical Services WST:US USD 18.8M 0